IMAB Long Term Debt vs Current Deferred Revenue Analysis

IMAB Stock

USD 0.95 0.11 10.45%

I Mab financial indicator trend analysis is infinitely more than just investigating I Mab recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether I Mab is a good investment. Please check the relationship between I Mab Long Term Debt and its Current Deferred Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.

Long Term Debt vs Current Deferred Revenue

Long Term Debt vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of I Mab Long Term Debt account and Current Deferred Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between I Mab's Long Term Debt and Current Deferred Revenue is 0.88. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of I Mab, assuming nothing else is changed. The correlation between historical values of I Mab's Long Term Debt and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of I Mab are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Long Term Debt i.e., I Mab's Long Term Debt and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.88

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that I Mab has held for over one year. Long-term debt appears on I Mab balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on I Mab balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from I Mab's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into I Mab current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.Tax Provision is expected to grow at the current pace this year. In addition to that, Selling General Administrative is expected to decline to about 60.7 M

	2022	2023	2024 (projected)
Interest Expense	1.3K	101.9K	96.8K
Depreciation And Amortization	25.3M	23.9M	20.6M

Interest Expense Depreciation And Amortization

I Mab fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity
Total Assets		-0.81	0.86	0.85	0.92	0.84	0.62	-0.7	-0.98	-0.57	-0.43	0.89	0.82	-0.79	-0.81	0.99	0.72	-0.16	0.83	0.78	0.07	-0.77	-0.45	0.75	0.39	0.68
Short Long Term Debt Total	-0.81		-0.86	-0.83	-0.7	-0.87	-0.25	0.87	0.86	0.85	0.63	-0.56	-0.41	0.65	0.92	-0.85	-0.31	0.63	-0.92	-0.89	0.41	0.9	0.35	-0.9	0.03	-0.77
Other Current Liab	0.86	-0.86		0.99	0.69	0.73	0.64	-0.88	-0.89	-0.76	-0.64	0.75	0.57	-0.93	-0.92	0.88	0.56	-0.28	0.82	0.9	-0.12	-0.89	-0.22	0.93	0.36	0.56
Total Current Liabilities	0.85	-0.83	0.99		0.65	0.68	0.66	-0.86	-0.87	-0.72	-0.57	0.75	0.56	-0.92	-0.92	0.87	0.56	-0.22	0.77	0.86	-0.09	-0.9	-0.14	0.9	0.41	0.51
Total Stockholder Equity	0.92	-0.7	0.69	0.65		0.9	0.57	-0.55	-0.9	-0.52	-0.51	0.81	0.81	-0.65	-0.61	0.92	0.65	-0.18	0.84	0.74	0.15	-0.53	-0.74	0.65	0.23	0.72
Net Tangible Assets	0.84	-0.87	0.73	0.68	0.9		0.4	-0.73	-0.84	-0.81	-0.71	0.57	0.51	-0.55	-0.73	0.86	0.41	-0.56	0.98	0.89	-0.1	-0.66	-0.75	0.8	-0.13	0.89
Property Plant And Equipment Net	0.62	-0.25	0.64	0.66	0.57	0.4		-0.4	-0.58	-0.33	-0.29	0.7	0.59	-0.72	-0.47	0.62	0.73	0.26	0.43	0.55	0.63	-0.42	-0.23	0.43	0.61	0.22
Current Deferred Revenue	-0.7	0.87	-0.88	-0.86	-0.55	-0.73	-0.4		0.71	0.86	0.69	-0.42	-0.34	0.7	0.88	-0.73	-0.49	0.62	-0.83	-0.88	0.2	0.87	0.2	-0.96	0.02	-0.76
Net Debt	-0.98	0.86	-0.89	-0.87	-0.9	-0.84	-0.58	0.71		0.61	0.46	-0.9	-0.78	0.82	0.86	-0.99	-0.63	0.21	-0.84	-0.82	0.05	0.82	0.41	-0.78	-0.39	-0.64
Retained Earnings	-0.57	0.85	-0.76	-0.72	-0.52	-0.81	-0.33	0.86	0.61		0.79	-0.26	-0.06	0.49	0.8	-0.64	-0.15	0.77	-0.89	-0.92	0.26	0.78	0.39	-0.87	0.29	-0.77
Accounts Payable	-0.43	0.63	-0.64	-0.57	-0.51	-0.71	-0.29	0.69	0.46	0.79		-0.2	-0.13	0.54	0.47	-0.46	-0.09	0.56	-0.75	-0.8	0.29	0.41	0.61	-0.82	0.27	-0.57
Cash	0.89	-0.56	0.75	0.75	0.81	0.57	0.7	-0.42	-0.9	-0.26	-0.2		0.91	-0.83	-0.64	0.88	0.72	0.23	0.55	0.57	0.18	-0.6	-0.27	0.51	0.73	0.3
Non Current Assets Total	0.82	-0.41	0.57	0.56	0.81	0.51	0.59	-0.34	-0.78	-0.06	-0.13	0.91		-0.71	-0.44	0.77	0.84	0.27	0.45	0.4	0.29	-0.39	-0.36	0.41	0.66	0.35
Non Currrent Assets Other	-0.79	0.65	-0.93	-0.92	-0.65	-0.55	-0.72	0.7	0.82	0.49	0.54	-0.83	-0.71		0.74	-0.79	-0.64	-0.04	-0.61	-0.73	0.01	0.71	0.15	-0.79	-0.62	-0.31
Long Term Debt	-0.81	0.92	-0.92	-0.92	-0.61	-0.73	-0.47	0.88	0.86	0.8	0.47	-0.64	-0.44	0.74		-0.85	-0.46	0.47	-0.82	-0.87	0.2	0.99	0.09	-0.86	-0.22	-0.65
Cash And Short Term Investments	0.99	-0.85	0.88	0.87	0.92	0.86	0.62	-0.73	-0.99	-0.64	-0.46	0.88	0.77	-0.79	-0.85		0.68	-0.22	0.87	0.83	0.04	-0.81	-0.45	0.78	0.35	0.7
Net Receivables	0.72	-0.31	0.56	0.56	0.65	0.41	0.73	-0.49	-0.63	-0.15	-0.09	0.72	0.84	-0.64	-0.46	0.68		0.17	0.41	0.41	0.58	-0.43	-0.2	0.42	0.57	0.44
Good Will	-0.16	0.63	-0.28	-0.22	-0.18	-0.56	0.26	0.62	0.21	0.77	0.56	0.23	0.27	-0.04	0.47	-0.22	0.17		-0.62	-0.57	0.47	0.46	0.3	-0.56	0.73	-0.73
Common Stock Total Equity	0.83	-0.92	0.82	0.77	0.84	0.98	0.43	-0.83	-0.84	-0.89	-0.75	0.55	0.45	-0.61	-0.82	0.87	0.41	-0.62		0.95	-0.14	-0.76	-0.63	0.88	-0.12	0.89
Common Stock Shares Outstanding	0.78	-0.89	0.9	0.86	0.74	0.89	0.55	-0.88	-0.82	-0.92	-0.8	0.57	0.4	-0.73	-0.87	0.83	0.41	-0.57	0.95		-0.12	-0.82	-0.48	0.93	0.01	0.76
Short Term Investments	0.07	0.41	-0.12	-0.09	0.15	-0.1	0.63	0.2	0.05	0.26	0.29	0.18	0.29	0.01	0.2	0.04	0.58	0.47	-0.14	-0.12		0.23	-0.12	-0.28	0.35	-0.02
Long Term Debt Total	-0.77	0.9	-0.89	-0.9	-0.53	-0.66	-0.42	0.87	0.82	0.78	0.41	-0.6	-0.39	0.71	0.99	-0.81	-0.43	0.46	-0.76	-0.82	0.23		0.0	-0.84	-0.22	-0.6
Non Current Liabilities Total	-0.45	0.35	-0.22	-0.14	-0.74	-0.75	-0.23	0.2	0.41	0.39	0.61	-0.27	-0.36	0.15	0.09	-0.45	-0.2	0.3	-0.63	-0.48	-0.12	0.0		-0.34	0.31	-0.62
Capital Surpluse	0.75	-0.9	0.93	0.9	0.65	0.8	0.43	-0.96	-0.78	-0.87	-0.82	0.51	0.41	-0.79	-0.86	0.78	0.42	-0.56	0.88	0.93	-0.28	-0.84	-0.34		0.03	0.71
Other Current Assets	0.39	0.03	0.36	0.41	0.23	-0.13	0.61	0.02	-0.39	0.29	0.27	0.73	0.66	-0.62	-0.22	0.35	0.57	0.73	-0.12	0.01	0.35	-0.22	0.31	0.03		-0.35
Other Stockholder Equity	0.68	-0.77	0.56	0.51	0.72	0.89	0.22	-0.76	-0.64	-0.77	-0.57	0.3	0.35	-0.31	-0.65	0.7	0.44	-0.73	0.89	0.76	-0.02	-0.6	-0.62	0.71	-0.35

Click cells to compare fundamentals

I Mab Account Relationship Matchups

I Mab fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.7B	6.3B	5.6B	4.1B	2.6B	3.7B
Short Long Term Debt Total	132.5M	13.6M	112.5M	75.0M	18.9M	17.9M
Other Current Liab	531.7M	567.4M	593.3M	637.3M	402.9M	468.7M
Total Current Liabilities	588.5M	576.1M	624.0M	659.7M	411.8M	534.5M
Total Stockholder Equity	(2.0B)	5.6B	4.6B	3.0B	1.7B	1.8B
Other Liab	2.5M	3.9M	125.0M	335.8M	386.2M	405.5M
Net Tangible Assets	(1.3B)	(2.3B)	5.3B	4.3B	5.0B	5.2B
Property Plant And Equipment Net	46.5M	40.3M	158.5M	124.0M	11.7M	11.1M
Current Deferred Revenue	3.9M	7.5M	2.4M	8.7M	1.6M	1.5M
Net Debt	(1.0B)	(4.7B)	(3.4B)	(3.1B)	(2.0B)	(2.1B)
Retained Earnings	(2.5B)	(2.0B)	(4.4B)	(6.8B)	(8.3B)	(7.9B)
Accounts Payable	67.7M	(3.9M)	(2.4M)	(33.1M)	(29.8M)	(28.3M)
Cash	1.1B	4.8B	3.5B	3.2B	302.1M	287.0M
Non Current Assets Total	376.3M	990.1M	847.7M	447.2M	276.3M	262.5M
Non Currrent Assets Other	18.3M	2.0M	26.6M	10.9M	246.2M	258.5M
Other Assets	18.3M	2.0M	26.6M	237.3M	272.9M	286.6M
Cash And Short Term Investments	1.2B	4.8B	4.3B	3.4B	2.3B	2.9B
Net Receivables	55.9M	130.5M	286.9M	4.8M	2.5M	2.4M
Common Stock Shares Outstanding	57.8M	68.4M	76.0M	82.5M	83.2M	71.8M
Short Term Investments	32M	31.5M	753.2M	235.4M	20.2M	19.2M
Liabilities And Stockholders Equity	1.7B	6.3B	5.6B	4.1B	2.6B	3.7B
Non Current Liabilities Total	3.2B	130.5M	417.6M	405.6M	483.0M	458.8M
Capital Lease Obligations	14.3M	13.6M	112.5M	56.0M	45.0M	37.9M
Inventory	(55.9M)	(422.9M)	27.2M	(80.3M)	12.8M	13.4M
Other Current Assets	191.8M	195.5M	190.8M	172.5M	31.8M	30.2M
Other Stockholder Equity	(2.7B)	5.7B	9.1B	1.2B	10.0B	10.5B
Total Liab	3.8B	706.6M	1.0B	1.1B	894.8M	1.4B
Net Invested Capital	(1.9B)	5.6B	4.6B	3.0B	1.8B	1.9B
Property Plant And Equipment Gross	46.5M	40.3M	158.5M	124.0M	156.4M	90.5M
Total Current Assets	1.4B	5.3B	4.8B	3.6B	2.3B	3.2B
Accumulated Other Comprehensive Income	70.1M	(50.8M)	(186.5M)	216.7M	42.1M	24.6M
Net Working Capital	772.8M	4.8B	4.2B	3.0B	1.9B	2.6B
Short Term Debt	56.8M	(33.6M)	30.7M	22.4M	7.3M	7.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether I Mab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of I Mab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of I Mab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on I Mab Stock:

How To Invest In IMAB

Details

Is IMAB Stock a good investment?

Details

What is I Mab's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of I Mab. If investors know IMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about I Mab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.16)

Revenue Per Share

0.043

Quarterly Revenue Growth

(0.62)

Return On Assets

(0.29)

Return On Equity

(0.72)

The market value of I Mab is measured differently than its book value, which is the value of IMAB that is recorded on the company's balance sheet. Investors also form their own opinion of I Mab's value that differs from its market value or its book value, called intrinsic value, which is I Mab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because I Mab's market value can be influenced by many factors that don't directly affect I Mab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between I Mab's value and its price as these two are different measures arrived at by different means. Investors typically determine if I Mab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, I Mab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IMAB Long Term Debt vs Current Deferred Revenue Analysis

Long Term Debt vs Current Deferred Revenue

Long Term Debt vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Long Term Debt

Current Deferred Revenue

I Mab fundamental ratios Correlations

I Mab Account Relationship Matchups

High Positive Relationship

High Negative Relationship

I Mab fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab
Long Term Debt Total	+ 0.99	Long Term Debt
Common Stock Total Equity	+ 0.98	Net Tangible Assets
Common Stock Shares Outstanding	+ 0.95	Common Stock Total Equity
Capital Surpluse	+ 0.93	Other Current Liab

Cash And Short Term Investments	- 0.99	Net Debt
Net Debt	- 0.98	Total Assets
Capital Surpluse	- 0.96	Current Deferred Revenue
Non Currrent Assets Other	- 0.93	Other Current Liab
Common Stock Shares Outstanding	- 0.92	Retained Earnings
Long Term Debt	- 0.92	Total Current Liabilities